165 related articles for article (PubMed ID: 23724280)
21. Comparative health risk assessment of realgar and NiuHuangJieDu tablets based on tissue arsenic levels after multiple oral administration to rats.
Wu X; Guan R; Liu Y; Wu S; Song M; Hang T
J Ethnopharmacol; 2020 Mar; 249():112370. PubMed ID: 31683032
[TBL] [Abstract][Full Text] [Related]
22. The medicinal use of realgar (As₄S₄) and its recent development as an anticancer agent.
Wu J; Shao Y; Liu J; Chen G; Ho PC
J Ethnopharmacol; 2011 Jun; 135(3):595-602. PubMed ID: 21497649
[TBL] [Abstract][Full Text] [Related]
23. Toxic epidermal necrolysis after extensive dermal use of realgar-containing (arsenic sulfide) herbal ointment.
Wu ML; Deng JF
Clin Toxicol (Phila); 2013; 51(8):801-3. PubMed ID: 24003889
[TBL] [Abstract][Full Text] [Related]
24. [Preliminary study of Realgar and arsenic trioxide on gut microbiota of mice].
Sun YT; Xu HH; Nie Y; Wang YG; Ma ZC; Zhou W; Tan HL; Gao Y
Zhongguo Zhong Yao Za Zhi; 2020 Jan; 45(1):142-148. PubMed ID: 32237423
[TBL] [Abstract][Full Text] [Related]
25. UPLC/Q-TOFMS-Based Metabolomics Approach to Reveal the Protective Role of Other Herbs in An-Gong-Niu-Huang Wan Against the Hepatorenal Toxicity of Cinnabar and Realgar.
Xia F; Li A; Chai Y; Xiao X; Wan J; Li P; Wang Y
Front Pharmacol; 2018; 9():618. PubMed ID: 29950994
[TBL] [Abstract][Full Text] [Related]
26. [Asenic accumulation following realgar administration in rats].
Li C; Liang A; Wang J; Xue B; Li H; Yang B; Wang J; Xie Q; Nilsen OG; Zhang B
Zhongguo Zhong Yao Za Zhi; 2011 Jul; 36(14):1895-900. PubMed ID: 22016955
[TBL] [Abstract][Full Text] [Related]
27. [Research progress in mineral Chinese medicine realgar].
Song LL; Han DY; Lin RC; Huang JM; Guan J
Zhongguo Zhong Yao Za Zhi; 2019 Feb; 44(3):433-440. PubMed ID: 30989904
[TBL] [Abstract][Full Text] [Related]
28. Data on the sub-chronic toxicity in rats after 30 days of oral realgar administration and the accumulation and distribution of arsenic species.
Yi Y; Gao S; Xia J; Li C; Zhao Y; Zhang Y; Liang A; Ji S
Data Brief; 2019 Apr; 23():103572. PubMed ID: 31372375
[TBL] [Abstract][Full Text] [Related]
29. Fatal acute arsenic poisoning by external use of realgar: Case report and 30 years literature retrospective study in China.
Zheng J; Zhang K; Liu Y; Wang Y
Forensic Sci Int; 2019 Jul; 300():e24-e30. PubMed ID: 31023496
[TBL] [Abstract][Full Text] [Related]
30. Assessment of the solubility and bioaccessibility of arsenic in realgar wine using a simulated gastrointestinal system.
Zhang YN; Sun GX; Williams PN; Huang Q; Zhu YG
Sci Total Environ; 2011 May; 409(12):2357-60. PubMed ID: 21470664
[TBL] [Abstract][Full Text] [Related]
31. Realgar-induced nephrotoxicity via ferroptosis in mice.
Zhang S; Cao S; Zhou H; Li L; Hu Q; Mao X; Ji S
J Appl Toxicol; 2022 Nov; 42(11):1843-1853. PubMed ID: 35803278
[TBL] [Abstract][Full Text] [Related]
32. Reversal effect of arsenic sensitivity in human leukemia cell line K562 and K562/ADM using realgar transforming solution.
Wang X; Zhang X; Xu Z; Wang Z; Yue X; Li H
Biol Pharm Bull; 2013; 36(4):641-8. PubMed ID: 23358330
[TBL] [Abstract][Full Text] [Related]
33. [Toxicity study of realgar].
Liang A; Li C; Wang J; Xue B; Li H; Yang B; Wang J; Xie Q; Nilsen OG
Zhongguo Zhong Yao Za Zhi; 2011 Jul; 36(14):1889-94. PubMed ID: 22016954
[TBL] [Abstract][Full Text] [Related]
34. The Herbal Constituents in An-Gong-Niu-Huang Wan (AGNH) Protect against Cinnabar- and Realgar-Induced Hepatorenal Toxicity and Accumulations of Mercury and Arsenic in Mice.
Wang S; Xiao X; Li A; Li P
Evid Based Complement Alternat Med; 2021; 2021():5566078. PubMed ID: 33868437
[TBL] [Abstract][Full Text] [Related]
35. Realgar (As4S4) nanoparticles and arsenic trioxide (As2O3) induced autophagy and apoptosis in human melanoma cells in vitro.
Pastorek M; Gronesova P; Cholujova D; Hunakova L; Bujnakova Z; Balaz P; Duraj J; Lee TC; Sedlak J
Neoplasma; 2014; 61(6):700-9. PubMed ID: 25150315
[TBL] [Abstract][Full Text] [Related]
36. Arsenic concentration in peripheral blood is correlated with efficacy of a Traditional Chinese Medicine regimen containing realgar for the treatment of myelodysplastic syndrome.
Wang DX; Xu YG; Du Y; Wang HZ; Li L; Hu XM; Yang XP; Ma R; Zhou QB
J Tradit Chin Med; 2021 Aug; 41(4):630-635. PubMed ID: 34392657
[TBL] [Abstract][Full Text] [Related]
37. Arsenic Bioaccessibility of Realgar Influenced by the Other Traditional Chinese Medicines in Niuhuang Jiedu Tablet and the Roles of Gut Microbiota.
Xu W; Xu S; Zhang S; Wu X; Jin P
Evid Based Complement Alternat Med; 2019; 2019():8496817. PubMed ID: 31929821
[TBL] [Abstract][Full Text] [Related]
38. Comparative analysis of immunological changes following realgar and arsenic trioxide treatments in a murine model of myelodysplastic syndrome.
Tao Y; Xue T; Li X; Guo R; Wang Y; Xu H; Hu K; Dong X; Wang D; Ren J; Guan Y; Lu J
Immunopharmacol Immunotoxicol; 2024 Jun; 46(3):408-416. PubMed ID: 38816179
[TBL] [Abstract][Full Text] [Related]
39. Arsenic sulfide, the main component of realgar, a traditional Chinese medicine, induces apoptosis of gastric cancer cells in vitro and in vivo.
Zhang L; Tian W; Kim S; Ding W; Tong Y; Chen S
Drug Des Devel Ther; 2015; 9():79-92. PubMed ID: 25565771
[TBL] [Abstract][Full Text] [Related]
40. (1)H NMR-based metabonomics study on the toxicity alleviation effect of other traditional Chinese medicines in Niuhuang Jiedu tablet to realgar (As2S2).
Xu W; Wang H; Chen G; Li W; Xiang R; Pei Y
J Ethnopharmacol; 2013 Jun; 148(1):88-98. PubMed ID: 23583735
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
